Ovulation Suppression

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AT
Agile TherapeuticsNJ - Princeton
1 program
1
levonorgestrel and ethinyl estradiolPhase 21 trial
Active Trials
NCT01250210Completed123Est. Feb 2008

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Agile Therapeuticslevonorgestrel and ethinyl estradiol

Clinical Trials (1)

Total enrollment: 123 patients across 1 trials

NCT01250210Agile Therapeuticslevonorgestrel and ethinyl estradiol

Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

Start: Sep 2007Est. completion: Feb 2008123 patients
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space